GGrantIndex
← Search

Rapid Diagnostic for HCMV Serological Status

$224,887N43FY2017AINIH

Nanocomposix, Inc., San Diego CA

Investigators

Abstract

To develop a point-of-care diagnostic to detect the presence of IgG and IgM antibodies against human cytomegalovirus (HCMV)

View original record on NIH RePORTER →
Rapid Diagnostic for HCMV Serological Status · GrantIndex